Douglas A Roeder

Director Douglas Roeder adds 22,686 shares while stock trades down 63% from 52-week high; repeat buyer at declining prices in loss-making medical device company.

Director Douglas Roeder purchased over 22,600 shares, increasing his stake by nearly one-fifth—his sixth open-market purchase in the last three years. The timing is notable: the stock is trading well below its 52-week high and has declined significantly over the past several months, suggesting he is buying during a sustained pullback rather than at peak levels. Senseonics is not yet profitable and posted a net loss in both the full year and most recent quarter, though the company is growing revenue at a strong rate year-over-year. Roeder has no track record of open-market sales and has consistently added shares on the open market, but all five of his prior purchases at this ticker remain too recent to assess whether they preceded gains or further declines. His repeated buying into a falling stock in a loss-making but growing medical device company could reflect conviction in a longer-term turnaround, but the pattern of purchases at steadily lower prices over several years warrants scrutiny about whether he is averaging down into a deteriorating situation.

Director Roeder bought 17,500 SENS shares at $5.73 on 2026-03-13, extending 4-of-4 well-timed buy pattern (+2136.7% to +3692.2% 90d returns prior).

Douglas A. Roeder (Director) purchased 17,500 shares at $5.73, increasing his stake by 17.1% to 119,731 shares. This marks his fifth open-market buy at Senseonics, following four prior purchases all characterized by substantial 90-day returns: +2136.7% (2023-08-30), +3692.2% (2024-12-12), +3009.6% (2024-12-13), and +13.6% (2025-11-07). Across his cross-ticker track record, his buy transactions average +2213.0% 30-day return and +1783.0% 90-day return with a 100.00% win rate, establishing a pattern of well-timed accumulation. The current stock price of $6.31 is -59.1% from the 52-week high of $15.44 and has declined -16.0% over 30 days, while fundamentals show the company posted $8,095,000.00 in latest quarterly revenue with net income of -$19,530,000.00—unprofitable but growing revenue +56.9% year-over-year. The scale and consistency of prior gains at this ticker, combined with a director-level insider choosing to significantly increase holdings despite recent stock weakness, suggests confidence in valuation at this price level relative to medium-term prospects.

Director Roeder buys 15,000 SENS shares at $5.83; 3 other insiders also bought within 14 days amid stock -75.8% from 52-week high.

Douglas Roeder, a Director, purchased 15,000 shares at $5.83 on 2025-11-07, increasing his holdings by 17.7% to 99.7K shares. This transaction is noteworthy because it occurs within a cluster: 3 other insiders also bought SENS within the past 14 days, suggesting coordinated conviction at depressed valuations. Roeder's own timing record at this ticker is strong—his prior 3 buys at SENS all posted positive 90-day returns (ranging from +2053.0% to +2893.7%), and all 3 were well-timed at the 90-day mark. However, the stock has deteriorated significantly since the transaction: the current price of $6.33 is -75.8% below the 52-week high of $26.20 and down -24.6% over the prior 30 days. Against this backdrop, the company remains unprofitable (net income of $-19.5M over the full year) despite flat annual revenue growth of +0.4%, creating material uncertainty about the validity of even Roeder's previously reliable timing edge at this ticker.

Director Roeder purchases 325,000 shares at $0.42 avg; 2 separate buys in cluster pattern with stock up +55.6% YTD

Douglas A. Roeder, Director at Senseonics Holdings, executed 2 separate purchases totaling 325,000 shares (325.0K shares) for $135,500.00 ($135.5K) on 2024-12-12 and 2024-12-13, increasing his holdings by 29.9% to 1,413,087 shares. The stock is trading at $8.81 current price, up 55.6% over the past 30 days but down 39.7% from its 52-week high of $14.60. Notably, 2 other insiders also bought within the past 14 days, forming a cluster buy pattern. Context is critical: Senseonics remains deeply unprofitable (net income of $-23,976,000.00 for the latest full fiscal year), though annual revenue growth of 3313.1% indicates rapid business expansion; the company's market cap stands at $5.2B despite minimal current profitability and quarterly revenue of only $4.3M.